Abstract
Background: The purpose of this study was to investigate the role of miR- 148b in liver injury in rats with traumatic hemorrhagic shock (THS) and to elucidate its potential mechanism.
Methods: The levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum of rats were detected by enzyme-linked immune sorbent assay (ELISA), and the injury of rat liver was analyzed by hematoxylin-eosin (H&E) staining. Apoptosis of rat hepatocytes and normal rat liver cell line (BRL3A) was identified by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay and flow cytometry, respectively. MiR-148b and sirtuin 6 (SIRT6) expression was measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot. Lactate dehydrogenase (LDH) content and cell viability were measured by commercial kits and cell counting kit-8 (CCK-8) assay, respectively. The binding sites of miR-148b and SIRT6 were predicted by the Starbase database and verified by dual luciferase reporter assay.
Results: MiR-148b expression in THS rats or ischemia-reperfusion (I/R)-treated cells was higher than in the control group. Overexpression of miR-148b further promoted the effects of I/R, which enhanced the levels of ALT, AST and LDH, cell apoptosis of liver tissue or BRL3A cells and decreased the expression of SITR6. Besides, miR-148b negatively correlated with SIRT6, and upregulated the expression of SIRT6 could partly reverse the effect of miR-148b.
Conclusion: Hepatocyte injury induced by I/R was achieved by regulating miR-148b /SIRT6 axis
[PMID: 6427656]
[PMID: 24089002]
[PMID: 25752214]
[PMID: 26646458]
[http://dx.doi.org/10.1007/s13730-020-00540-3] [PMID: 33038002]
[http://dx.doi.org/10.2741/4347] [PMID: 25961533]
[http://dx.doi.org/10.1093/abbs/gmx144.] [PMID: 29377979]
[http://dx.doi.org/10.1016/j.molmed.2010.03.004] [PMID: 20434954]
[http://dx.doi.org/10.1038/cdd.2010.119] [PMID: 20885442]
[http://dx.doi.org/10.1155/2020/4132785] [PMID: 33343806]
[http://dx.doi.org/10.3390/ijms20215266]
[http://dx.doi.org/10.1136/gutjnl-2020-322526] [PMID: 33127832]
[http://dx.doi.org/10.1002/jcp.28401] [PMID: 30820984]
[http://dx.doi.org/10.1002/hep.31221] [PMID: 32155285]
[http://dx.doi.org/10.1016/j.freeradbiomed.2017.11.005.] [PMID: 29129519]
[http://dx.doi.org/10.1186/s13049-018-0572-4.] [PMID: 30558650]
[http://dx.doi.org/10.1097/TA.0000000000001816.] [PMID: 29370058]
[http://dx.doi.org/10.1016/j.freeradbiomed.2015.05.030] [PMID: 26032169]
[http://dx.doi.org/10.1042/BSR20150084]
[http://dx.doi.org/10.1038/s41419-020-2308-4] [PMID: 32051395]
[http://dx.doi.org/10.1080/13813455.2020.1764051.] [PMID: 32551941]